Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% year-over-year; regulatory submission for prefilled syringe ...
The TMS platform is trusted by 500+ fleets across North America, creating 90% driver retention with proven gains in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback